The patent EP3932932B1 was granted to Sage Therapeutics on Jul 16, 2025 following the initial filing on Mar 13, 2014 under the application number EP21172859A . The current legal status of the patent is Granted And Under Opposition.
The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.
Date
Description
Get instant alerts for new documents